RecruitingNot ApplicableNCT06405750

Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate


Sponsor

University Hospital Bispebjerg and Frederiksberg

Enrollment

1,000 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the project is to elucidate whether it is possible to identify which patients are at risk of forming blood clots that can cause stroke based on analysis of the electrocardiogram. In connection with the operation, the small pouch known as the auricle of the heart is closed, which can be completely removed after closing. This procedure is common in patients with atrial fibrillation to protect the brain from stroke. In the project, all patients will have this auricle closed if they agree to participate in the project. After closure, the auricle is usually discarded. We will analyze the blood and the auricle tissue taken (if available) in connection with the operation itself, together with the analysis of the electrocardiogram recorded before the planned heart operation.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • signed informed consent AND
  • planned any open-heart surgery:
  • CABG
  • valve repair or replacement
  • aorta surgery
  • any combination of the above

Exclusion Criteria2

  • current endocarditis
  • follow-up not possible

Interventions

PROCEDUREleft atrial appendage closure

systematic closure of the left atrial appendage in addition to the planned heart surgery


Locations(1)

Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06405750


Related Trials